S&P 500   3,390.88 (-2.15%)
DOW   27,585.52 (-2.65%)
QQQ   278.86 (-2.07%)
AAPL   114.04 (-0.87%)
MSFT   209.58 (-3.08%)
FB   275.37 (-3.31%)
GOOGL   1,575.90 (-3.50%)
AMZN   3,188.87 (-0.48%)
TSLA   416.30 (-1.03%)
NVDA   523.00 (-3.79%)
BABA   305.80 (-1.33%)
CGC   18.72 (-5.12%)
GE   7.32 (-4.06%)
MU   51.71 (-2.16%)
AMD   81.98 (+0.02%)
T   27.27 (-1.98%)
F   8.01 (-1.84%)
ACB   4.44 (-5.13%)
GILD   59.76 (-1.69%)
NFLX   485.64 (-0.54%)
NIO   25.97 (-4.38%)
BA   160.00 (-4.40%)
DIS   123.29 (-3.94%)
S&P 500   3,390.88 (-2.15%)
DOW   27,585.52 (-2.65%)
QQQ   278.86 (-2.07%)
AAPL   114.04 (-0.87%)
MSFT   209.58 (-3.08%)
FB   275.37 (-3.31%)
GOOGL   1,575.90 (-3.50%)
AMZN   3,188.87 (-0.48%)
TSLA   416.30 (-1.03%)
NVDA   523.00 (-3.79%)
BABA   305.80 (-1.33%)
CGC   18.72 (-5.12%)
GE   7.32 (-4.06%)
MU   51.71 (-2.16%)
AMD   81.98 (+0.02%)
T   27.27 (-1.98%)
F   8.01 (-1.84%)
ACB   4.44 (-5.13%)
GILD   59.76 (-1.69%)
NFLX   485.64 (-0.54%)
NIO   25.97 (-4.38%)
BA   160.00 (-4.40%)
DIS   123.29 (-3.94%)
S&P 500   3,390.88 (-2.15%)
DOW   27,585.52 (-2.65%)
QQQ   278.86 (-2.07%)
AAPL   114.04 (-0.87%)
MSFT   209.58 (-3.08%)
FB   275.37 (-3.31%)
GOOGL   1,575.90 (-3.50%)
AMZN   3,188.87 (-0.48%)
TSLA   416.30 (-1.03%)
NVDA   523.00 (-3.79%)
BABA   305.80 (-1.33%)
CGC   18.72 (-5.12%)
GE   7.32 (-4.06%)
MU   51.71 (-2.16%)
AMD   81.98 (+0.02%)
T   27.27 (-1.98%)
F   8.01 (-1.84%)
ACB   4.44 (-5.13%)
GILD   59.76 (-1.69%)
NFLX   485.64 (-0.54%)
NIO   25.97 (-4.38%)
BA   160.00 (-4.40%)
DIS   123.29 (-3.94%)
S&P 500   3,390.88 (-2.15%)
DOW   27,585.52 (-2.65%)
QQQ   278.86 (-2.07%)
AAPL   114.04 (-0.87%)
MSFT   209.58 (-3.08%)
FB   275.37 (-3.31%)
GOOGL   1,575.90 (-3.50%)
AMZN   3,188.87 (-0.48%)
TSLA   416.30 (-1.03%)
NVDA   523.00 (-3.79%)
BABA   305.80 (-1.33%)
CGC   18.72 (-5.12%)
GE   7.32 (-4.06%)
MU   51.71 (-2.16%)
AMD   81.98 (+0.02%)
T   27.27 (-1.98%)
F   8.01 (-1.84%)
ACB   4.44 (-5.13%)
GILD   59.76 (-1.69%)
NFLX   485.64 (-0.54%)
NIO   25.97 (-4.38%)
BA   160.00 (-4.40%)
DIS   123.29 (-3.94%)
Log in
NASDAQ:PPH

VanEck Vectors Pharmaceutical ETF Stock Forecast, Price & News

$61.45
-1.01 (-1.62 %)
(As of 10/26/2020 01:53 PM ET)
Add
Today's Range
$61.45
Now: $61.45
$62.00
50-Day Range
$60.79
MA: $62.36
$64.04
52-Week Range
$46.90
Now: $61.45
$68.02
Volume704 shs
Average Volume60,668 shs
Market Capitalization$232.77 million
P/E RatioN/A
Dividend Yield1.62%
BetaN/A

Geographic Exposure of PPH

Currency Exposure of PPH

Sector Exposure of PPH

Industry Exposure of PPH

Basic Details

Issuer Van Eck
Fund NameVanEck Vectors Pharmaceutical ETF
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:PPH
Inception Date12/20/2011
Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkMarket Vectors US Listed Pharmaceutical 25 Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionGlobal

Fund Statistics

Assets Under Management$172.45 million
Average Daily Volume$38,061.10
Discount/Premium0.06%

ETF Expenses

Management Fee0.35%
Other Expenses0.05%
Total Expenses0.40%
Fee Waiver-0.05%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianThe Bank of New York Mellon Corporation
DistributorVan Eck Securities Corporation
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerIMC Chicago
$61.45
-1.01 (-1.62 %)
(As of 10/26/2020 01:53 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PPH News and Ratings via Email

Sign-up to receive the latest news and ratings for PPH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











VanEck Vectors Pharmaceutical ETF (NASDAQ:PPH) Frequently Asked Questions

How has VanEck Vectors Pharmaceutical ETF's stock been impacted by COVID-19 (Coronavirus)?

VanEck Vectors Pharmaceutical ETF's stock was trading at $56.63 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PPH stock has increased by 8.5% and is now trading at $61.45.
View which stocks have been most impacted by COVID-19
.

How often does VanEck Vectors Pharmaceutical ETF pay dividends? What is the dividend yield for VanEck Vectors Pharmaceutical ETF?

VanEck Vectors Pharmaceutical ETF announced a quarterly dividend on Wednesday, September 30th. Shareholders of record on Friday, October 2nd will be paid a dividend of $0.249 per share on Wednesday, October 7th. This represents a $1.00 annualized dividend and a dividend yield of 1.62%. The ex-dividend date is Thursday, October 1st.
View VanEck Vectors Pharmaceutical ETF's dividend history
.

Are investors shorting VanEck Vectors Pharmaceutical ETF?

VanEck Vectors Pharmaceutical ETF saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 655,400 shares, an increase of 195.8% from the September 15th total of 221,600 shares. Based on an average trading volume of 45,100 shares, the short-interest ratio is presently 14.5 days.
View VanEck Vectors Pharmaceutical ETF's Short Interest
.

What other stocks do shareholders of VanEck Vectors Pharmaceutical ETF own?

What is VanEck Vectors Pharmaceutical ETF's stock symbol?

VanEck Vectors Pharmaceutical ETF trades on the NASDAQ under the ticker symbol "PPH."

How do I buy shares of VanEck Vectors Pharmaceutical ETF?

Shares of PPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is VanEck Vectors Pharmaceutical ETF's stock price today?

One share of PPH stock can currently be purchased for approximately $61.45.

How big of a company is VanEck Vectors Pharmaceutical ETF?

VanEck Vectors Pharmaceutical ETF has a market capitalization of $232.77 million.

This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.